Načítá se...
State-of-the-Art 2019 on Gene Therapy for Phenylketonuria
Phenylketonuria (PKU) is considered to be a paradigm for a monogenic metabolic disorder but was never thought to be a primary application for human gene therapy due to established alternative treatment. However, somewhat unanticipated improvement in neuropsychiatric outcome upon long-term treatment...
Uloženo v:
| Vydáno v: | Hum Gene Ther |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Mary Ann Liebert, Inc., publishers
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6763965/ https://ncbi.nlm.nih.gov/pubmed/31364419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2019.111 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|